dsfgdsfg
This week the FDA approved ADDyi/Flibanserin, the first drug to treat premenopausal women with Hypoactive Sexual Desire Disorder (HSDD).
“Woohoo! Finally!” you may be thinking. Before you go rushing off to “ask your doctor if ADDyi is right for you”, there are some things you should know.